Combined PDE4+MEK inhibition shows antiproliferative effects in NRASQ61 mutated melanoma preclinical models.
Louveau B, Reger De Moura C, Jouenne F, Sadoux A, Allayous C, Da Meda L, Bernard-Cacciarella M, Baroudjian B, Lebbé C, Mourah S, et al. Melanoma Res. 2024 Apr 1; 34(2):186-192. Epub 2023 Dec 22.